Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Income from Continuing Operations: 2009-2025

Historic Income from Continuing Operations for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$1.8 million.

  • Rockwell Medical's Income from Continuing Operations fell 209.01% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 312.10%. This contributed to the annual value of -$554,000 for FY2024, which is 93.68% up from last year.
  • As of Q3 2025, Rockwell Medical's Income from Continuing Operations stood at -$1.8 million, which was down 16.58% from -$1.6 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Income from Continuing Operations peaked at $1.7 million during Q3 2024, and registered a low of -$8.9 million during Q4 2021.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$1.6 million (2023), whereas its average is -$1.3 million.
  • As far as peak fluctuations go, Rockwell Medical's Income from Continuing Operations skyrocketed by 179.54% in 2024, and later tumbled by 632.88% in 2025.
  • Quarterly analysis of 5 years shows Rockwell Medical's Income from Continuing Operations stood at -$8.9 million in 2021, then soared by 73.59% to -$2.4 million in 2022, then skyrocketed by 31.71% to -$1.6 million in 2023, then surged by 51.70% to -$779,000 in 2024, then tumbled by 209.01% to -$1.8 million in 2025.
  • Its last three reported values are -$1.8 million in Q3 2025, -$1.6 million for Q2 2025, and -$1.6 million during Q1 2025.